Regulatory Focus™ > News Articles > 5 > Recon: Allergan to Sell Women’s Health and Infectious Disease Units

Recon: Allergan to Sell Women’s Health and Infectious Disease Units

Posted 30 May 2018 | By Ana Mulero 

Recon: Allergan to Sell Women’s Health and Infectious Disease Units

Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing.

In Focus: US In Focus: International Pharmaceuticals & Biotechnology
  • Why Some Patients Getting Drugmakers' Help Are Paying More (NPR)
  • Drugmakers struggle to find immunotherapy combinations for cancer (Financial Times)
  • Failed Bush-era drug-pricing program may make more sense under Trump (Politico)
  • Right-To-Try Doesn’t Help Patients, Hurts FDA, Drugmakers (Bloomberg)
  • A Glioblastoma Vaccine? Not Yet. (Science Magazine)
  • Ipsen and MD Anderson agree deal on promising cancer candidate (The Pharma Letter) (Press)
  • Biologics and Biosimilars Collective Intelligence Consortium Quarterly: Letter from the program director (BBCIC)
  • Sanofi’s internal memo after a subpoena illustrates concerns over MS drug marketing (STAT-$)
  • With $20 Million In Funding, Propeller Health Partners With Aptar Pharma To Make Digital Medicines (Forbes)
  • Investors Anxious To See Walgreens U.S. Drugstore Of The Future (Forbes)
  • Venter to leave Human Longevity as turnover at the top continues (Fierce)
  • Daiichi Sankyo US subsidiary, Luitpold Pharma to merge with its own subsidiaries (Pharmabiz)
Pharmaceutical and Biotechnology: Study Results, Filings and Designations
  • J&J hustles Legend’s promising BCMA CAR-T into PhI/II trial, winning an FDA green light to begin recruiting patients (Endpoints) (Press)
  • List of 2018 Medicines in Development for Cancer (PhRMA)
  • Are Big Clinical Trials Relevant? Researchers Disagree (WSJ)
  • Alzheimer's: Rethinking the 'One-Size-Fits-All' Approach (MedPage Today)
  • Xenon – P1 data provide more de-risking (Open Reading Frame)
  • Northwest Bio's long-awaited glioblastoma vaccine data see stock roller coaster (Fierce)
Medical Devices
  • ResMed to acquire home and hospice software dev HealthcareFirst (MassDevice)
  • Neurent cleans up $11M to fund in-office runny nose treatment (Fierce)
  • Saranas raises $2.8M to pilot its internal bleeding detector (Fierce)
  • Titan, Braeburn end licensing deal for implanted drug for opioid addicts (Fierce)
  • Genetic Privacy, Disease Prevention, and the Principle of Rescue (Wiley Online Library)
  • LifeCell launches prenatal test to detect genetic abnormalities in fetus (Pharmabiz)
  • AI Versus Dermatologists At Diagnosing Skin Cancer, Here Are The Results (Forbes)
  • Can This Bracelet Prevent Pregnancy? $30 Million Says Yes, Expert Not So Sure (Forbes)
  • DNA donors must demand stronger protection for genetic privacy (STAT)
  • K2M Receives FDA Clearance for BACS Patient-Specific Module (Press)
US: Assorted & Government
  • Courts criticize cuts to HHS' teen pregnancy program (Axios)
  • WellCare To Buy Meridian Health Plans And PBM For $2.5 Billion (Forbes)
  • Hurricane Maria's death toll could exceed 4,600, study estimates (CNBC)
  • GAO Makes MedPAC Appointments (GAO)
  • Big Data and Predictive Analytics: Recalibrating Expectations (JAMA)
  • The Cost of Prescription Drugs: Examining the President’s Blueprint ‘American Patients First’ to Lower Drug Prices (Senate HELP Committee)
  • Evaluation of Bulk Drug Substances Nominated for Use in Compounding Under Section 503B of the Federal Food, Drug, and Cosmetic Act (FDA)
Upcoming Meetings & Events Europe
  • More than 1 million patients forced to get a new GP after seven-fold rise in practice closures (The Telegraph)
  • Head of Sandoz UK becomes BGMA chair (Pharmafile)
  • EU regulatory data protection - UK court considers generics’ challenges to prior EC decisions authorising reference product (Lexology-$)
  • UK scientists first to 3D-print human corneas (Verdict Medical Devices)
  • NHS Wales Securely Open for Business - the Vault workspace for commercially sensitive information (ABPI)
  • EU ministers endorse Commission’s plans for research cloud (EC)
  • 12 applications for allocation of special funds related to medicinal cannabis (Danish Medicines Agency)
  • Strength and Opportunity in 2017: The landscape of the medical technology and biopharmaceutical sectors in the UK (HM Government)
  • Kent Imaging Announces CE Mark for New Multispectral Imaging Product, Kent's KD203 (Press)
  • Nipah virus: Key facts (WHO)
  • ‘Reprogrammed’ stem cells approved to mend human hearts for the first time (Nature)
  • Japan’s First Biosimilars for Enbrel, Herceptin Added to NHI Price List (Pharma Japan)
  • India-Indonesia sign 15 MoUs in fields of defence, railways, health (Economic Times)
  • Why Southeast Asia’s ‘irrational’ use of antibiotics could lead to dire consequences (Southeast Asia Globe)
  • India’s drug regulator expects to finalize new clinical trial rules in two months (Reuters)
  • India's Hidden Infertility Struggles (The Diplomat)
  • Indian pharma industry keen to adopt automation to transform operations going the digital way: Dr. Amit Biswas (Pharmabiz)
  • Intuitive Surgical goes direct in India (MassDevice)
  • Child health in India: 14 out of 20 states cut spending on key programmes (Business Standard)
Australia Canada
  • Gonorrhea, other sexually transmitted infections on the rise in Canada (The Canadian Press)
  • OPINION: Want health-care revenue? Make Canada a medical tourism destination (The Chronicle Herald)
  • Acerus Acquires Canadian Rights to Novel Pain Relief Product for Gynecological Procedures from Pharmanest (Press)
  • PharmaBoardroom Releases 'Healthcare and Life Sciences Review Canada' May 2018 Pharma Report (Press)
  • Brazil Extends National Flu Vaccination Program Until June 15th (The Rio Times)
  • Director Renato Porto talks about the Brazilian regulatory environment (Anvisa)
General Health & Other Interesting Articles
  • The main forces spurring health care mergers (Axios)
  • Want to earn $10k per month? Join the “journals mafia” (Retraction Watch)
  • Doctors Can Increase Vaccination Rates In Kids Using New Approach, Study Finds (Forbes)
  • Cancer group says colon screening should start at 45, not 50 (STAT)
  • Doctors can change vaccine-hesitant parents' minds by being persistent: study (Fierce)
Regulatory Reconnaissance is our daily intelligence briefing for the regulatory affairs space, bringing you the top regulatory news stories from around the globe. Each weekday morning, we aim to bring you the latest highlights of new approvals, meetings, legal and political developments, regulations and guidance, and the latest trends with the potential to impact regulatory affairs professionals and the industry in which they work.
Need to contact the editor of Regulatory Reconnaissance? Email us at
A story's inclusion in Regulatory Reconnaissance does not imply endorsement by Regulatory Focus or RAPS.

Categories: Regulatory News

Regulatory Focus newsletters

All the biggest regulatory news and happenings.